Related by context. All words. (Click for frequent words.) 62 NIH 61 SAIC Frederick 60 NIAID 59 indoor cave dwellers 58 Cancer Institute 56 Inc NCIT 55 NINDS 55 CALGB 55 NHLBI 55 NIH SBIR 55 SWOG 55 ACRIN 53 RTOG 53 Patricia Hartge 53 NIBIB 53 ORWH 52 National Institutes 52 caBIG 52 SPORE grant 52 EDRN 52 NIEHS 51 CDMRP 51 DF HCC 51 NIAMS 51 NIH NIAID 51 NCI Cancer 51 extramural research 51 NSABP 51 Translational Biology 50 FASgen 50 Genvec 50 Opexa 50 MSKCC 50 NICHD 50 NIGMS 50 DynPort 50 Radiation Therapy Oncology 50 Adherex 50 NHGRI 50 ELCAP 50 Cancer Biomedical Informatics 50 NCCN 50 Intramural Research 49 NIDDK 49 EntreMed 49 Trial PCPT 49 Integrated Preclinical 49 Prostate Cancer Prevention 49 Nanotechnology Characterization Laboratory 49 Kidney Diseases NIDDK 49 OSUCCC 49 BCIRG 49 NCCTG 49 Bexion 49 Developmental Therapeutics Program 49 Navigant Consulting Inc 49 Digital Mammographic Imaging 48 Translational Science Award 48 NSF SBIR 48 CHAVI 48 tubulin inhibitor 48 DOE NNSA 48 ICGC 48 Gynecologic Oncology Group 48 Screening Trial DMIST 48 TGen 48 OSUCCC James 48 CMCR 48 ParAllele 48 NCI CTEP 48 AHRQ 48 CTSAs 48 BIIR 48 Grid caBIG 48 Ovarian PLCO Cancer 48 Duke Comprehensive Cancer 48 Qualified Therapeutic Discovery 47 Lentigen 47 TrialNet 47 ENESTnd 47 CTSA consortium 47 EGEN 47 Phase Ib II 47 Onconova 47 DAIDS 47 CaPSURE 47 Screening Trial 47 OHRI 47 PCRP 47 NCCAM 47 Prostate Lung Colorectal 47 Tolerx 47 Cancer Genome Atlas 47 eRT 47 NCIT 47 NIH NHLBI 47 Niederhuber 47 AVADO 47 Destum Partners 47 EmergingMed 47 Dr. Varmus 47 WHI 47 Study ADCS 47 HIV AIDS Vaccine Immunology 47 Armed Forces Radiobiology Research 47 Developmental Therapeutics 47 VCU Massey 47 Velos eResearch 47 LSRO 47 LIAI 47 STTR grant 46 VIRxSYS 46 Ciphergen 46 QuantaLife 46 ChemImage 46 NINR 46 NCI Comprehensive Cancer 46 Excellence CCNE 46 Proellex TM 46 ORISE 46 National Heart Lung 46 AlphaMed Press 46 Expression Genetics 46 EORTC 46 PF # [002] 46 Dr. Nabel 46 GenPath 46 Pressure BioSciences 46 Intervention Trial GAIT 46 chemoprevention trials 46 NCMHD 46 OncoMethylome 46 Numoda 46 immatics 46 extramural grants 46 Neogenix 46 Oncolin 46 STTR 46 National Surgical Adjuvant 46 NIH NIDDK 46 Semafore 46 Galenea 46 ChondroGene 46 STRIDE PD 46 SSCI 46 Neuradiab 46 Evaluation Program CTEP 46 NCIC Clinical Trials 46 Bayer HealthCare Onyx Pharmaceuticals 46 UT Southwestern 46 Bostwick Laboratories 46 VTEU 46 PANVAC VF 46 Cancer Genome 46 EnVivo Pharmaceuticals Inc. 46 Genelabs 46 OGeS 46 Tesmilifene 46 enzastaurin 46 NIDCR 46 TNFerade TM 46 NCI designated 46 programs visit http:/www.nih.gov/ 46 ProMune 46 CPRIT 46 proteomic biomarkers 46 Mikros 45 Group RTOG 45 Perlegen 45 Biomarkers Consortium 45 Cancer Genetic Markers 45 Akonni Biosystems 45 Biomarker Discovery Center 45 farletuzumab 45 Cleveland BioLabs 45 Protein Structure Initiative 45 translational research 45 Xceleron 45 CIHR 45 Cetero Research 45 Kidney Diseases 45 GVAX Pancreas Vaccine 45 SBIR 45 Panacea Pharmaceuticals 45 EOIR Technologies 45 NABTT 45 SAEC 45 Hauptman Woodward 45 Molecular Profiling 45 Group B CALGB 45 ixabepilone 45 NHGRI Division 45 NPC 1C 45 MJFF 45 SBIR Phase 45 Agios Pharmaceuticals 45 QIMR 45 Avastin adjuvant 45 Source MDx 45 CINJ 45 WTCCC 45 Health NIH 45 StemEx R 45 Therapeutic Discovery Project 45 Singulex 45 Panacea Pharmaceuticals Inc. 45 epigenomics 45 QOPI 45 FoldRx 45 refractory metastatic 45 BARI 2D 45 OvaRex 45 AVAX 45 Pacific Biomarkers 45 Allovectin 7 45 IncellDx 45 HPCGG 45 National Coastwatch Institution 45 Inclinix 45 ARRY # 45 Cardioxyl Pharmaceuticals 45 PSMA ADC 45 CTRC 45 Oncimmune 45 Antigen Express 45 AAHC 45 Epizyme 45 Cristofanilli 45 Viatronix 45 NCRR 45 DFCI 45 NCIC CTG 45 ASCO GU 45 AIM HIGH 45 Scancell 45 CTSA 45 Immune Tolerance Network 45 tremelimumab 45 Nuvera Biosciences 45 AFRRI 45 Aureon 45 Neurologix 45 Functional Genetics 45 IASLC 45 ONCURA 45 PRESEPT 45 Hepatocellular Carcinoma HCC 45 Optivia Biotechnology 45 Translational Science 45 Investigator Initiated 45 RPCI 45 Serenex 45 recurrent metastatic 45 II SBIR 45 HPTN 45 Oncology Med 45 CGEMS 45 ZACTIMA 45 Neogenix Oncology 45 Tom Misteli 45 UNC Lineberger 45 Oncovir 45 Bowel Project NSABP 45 Sidney Kimmel Cancer 45 High Throughput Genomics 44 Epidemiological Studies Unit 44 UPCI 44 Inc. NASDAQ NCIT 44 OpGen 44 JCVI 44 ImmunoCellular Therapeutics 44 ALCMI 44 Genpathway 44 IGSP 44 UTHCT 44 Dr. Beilharz 44 Immunotherapeutic 44 collaborator Genentech 44 Francesca Bravi 44 BioMarck 44 Sopherion 44 OvaRex MAb 44 etrials 44 translational genomics 44 CDISC 44 Celsion 44 Federally Funded Research 44 KineMed 44 TCGA 44 Harold Varmus MD 44 OvaRex R 44 DTIC 44 Vaccinex 44 SBIR Grant 44 Chicago Multidisciplinary Symposium 44 NIH Roadmap 44 neoadjuvant treatment 44 IRX Therapeutics 44 NITRD 44 Hydra Biosciences 44 CDER 44 NIH grantees 44 C3 Jian 44 Cellumen 44 Caris Dx 44 WRAIR 44 JAK3 44 CSREES 44 Theranostics 44 Cardiocore 44 Acurian 44 CIMIT 44 UTHSCSA 44 Correlogic 44 Etubics 44 Cleveland Clinic Taussig 44 LUX Lung 44 Oncotech 44 Predictive Biosciences 44 Research Network EDRN 44 Bracco Diagnostics 44 HealthHelp 44 Breast Oncology 44 Almac Diagnostics 44 multicenter trials 44 anti angiogenic therapy 44 Hollings Cancer 44 BN ImmunoTherapeutics 44 Jose Baselga 44 DeCode 44 Receptor Logic 44 Nalini Ranjit 44 CAPRISA 44 NBTF 44 Arrayit Diagnostics 44 neratinib 44 Guilford Pharmaceuticals 44 Pediatric Oncology Branch 44 BioGeneriX 44 Patient Navigation 44 Intarcia 44 AdMeTech 44 pertuzumab 44 Cancer Epidemiology 44 Signal Genetics 44 Health Research CIHR 44 ASRT 44 PathFinderTG 44 Myocet 44 Anticancer Agents 44 Peer Reviewed Medical 44 DMIST 44 INTERPHONE 44 Lpath 44 IMC #B 44 HHMI 44 www.cancer.gov 44 Epiphany Biosciences 44 Clinical Translational 44 Lombardi Comprehensive Cancer 44 GenVec 44 Hollis Eden 44 Neurome 44 PPMD 44 Hodgkin lymphoma HL 44 I3P 44 Cleveland Biolabs 44 Comprehensive Cancer Center 44 ZenBio 44 eRA 44 Phase #b/#a clinical 44 Aplidin 44 Genome Sequencing Centers 44 Ovarian Cancer Screening 44 SeqWright 44 PRESEPT study 44 T DM1 44 Transgenomic 44 Bellicum 44 Saneron CCEL 44 PCPT 44 Research Resources NCRR 44 NAACCR 44 ASCO GI 44 SBRT 44 CDAS 44 Modrenal 44 ASCO 44 MUSC Hollings Cancer 44 prospective nonrandomized 44 NABsys 44 Glucosamine Chondroitin Arthritis 44 Tessella 44 San Antonio Breast Cancer 44 Power3 Medical 44 PGxHealth 44 Cancer Immunobiology Center 44 InfoZen 44 Velcade bortezomib 44 Angiolix 44 Lantheus Medical Imaging 44 Thoracic Oncology 44 Antisense Pharma 44 PROSTVAC TM 44 Dr. Ellen Vitetta 44 trastuzumab DM1 T DM1 44 Amorcyte 44 MammoSite RTS 44 AdvanceMed 44 indibulin 44 Genome Quebec 44 Caris Diagnostics 43 ENCODE 43 Beckman Coulter Genomics 43 Research CIHR 43 Dendreon Provenge 43 BioNumerik 43 CHARISMA trial 43 Gliknik 43 IMRT IGRT 43 COBRE 43 Experimental Therapeutics 43 PLCO 43 HHSN#C 43 BEIR 43 Victor Velculescu 43 Thorough QT 43 Nanotherapeutics 43 ImmunoGen 43 Cardiovascular Genetics 43 Curis 43 Human Microbiome Project 43 Elocalcitol 43 Principal Investigator PI 43 Kosan dependence 43 Sangamo BioSciences 43 Kolltan Pharmaceuticals 43 Molecular Libraries 43 VTEUs 43 Electronic Brachytherapy 43 Stroke NINDS 43 Cytopathology 43 PhaseBio 43 Daniel Junius 43 Mien Chie Hung 43 Johns Hopkins Sidney Kimmel 43 Bowel Project 43 Dr. Ayalew Tefferi 43 NIAID conducts 43 Dr. Pestell 43 SBIR Phase II 43 ImQuest 43 Canvaxin 43 Lorus Therapeutics 43 Oncology 43 SNS# T 43 DiscoveryBioMed 43 CancerGuide 43 Modular Genetics 43 Amarantus 43 Phase III TRIST 43 clinical trial 43 Jean Francois Rossignol 43 Cohort Consortium 43 DCVax R 43 Hedgehog antagonist 43 OICR 43 IAVI 43 InNexus 43 BRIM2 43 ATSDR 43 ORNL 43 P. Wilmot 43 AIDS Clinical Trials 43 NIH Clinical 43 drug conjugate 43 Nereus Pharmaceuticals 43 LibiGel Phase III 43 SBIR grant 43 Undiagnosed Diseases Program 43 Nephros Therapeutics 43 GAP #B# 43 GlycoMimetics 43 Scynexis 43 Cutaneous Oncology 43 BHGI 43 Naurex 43 Phase 2b RESTORE CLI 43 Neurological Diseases 43 Enobia 43 ASU Biodesign Institute 43 PATH Malaria Vaccine Initiative 43 AACR 43 Dr. Demetrius Albanes 43 cellular immunotherapy 43 LGLS 43 tesmilifene 43 Neuroepidemiology 43 Theratope 43 Pharm Olam 43 PharmaNova 43 Open Biosystems 43 selenium supplementation 43 NanoString 43 CellCiphr 43 Dana-Farber/Harvard Cancer Center 43 NIAID Vaccine Research 43 GLOBOCAN 43 Jennerex 43 Cellular Immunology 43 Immunicon dependence 43 UMMS 43 Avila Therapeutics 43 Accelovance 43 Dr. Von Hoff 43 Vion Pharmaceuticals 43 experimental therapeutics 43 Proxinium TM 43 FivePrime 43 FFRDC 43 MEND CABG II 43 UCLA Jonsson Comprehensive Cancer 43 Curaxin 43 Extramural Research 43 SABCS 43 Ruth L. Kirschstein 43 Sensus Healthcare 43 IL# PE#QQR 43 randomized discontinuation trial 43 Celera 43 Argos Therapeutics 43 ViroLogic 43 drug conjugate ADC 43 oral deforolimus 43 NEI 43 ENDEAVOR IV 43 Semafore Pharmaceuticals 43 RayBiotech 43 Common Toxicity Criteria 43 gefitinib Iressa 43 BLP# Liposome Vaccine 43 Dr. Victor Velculescu 43 NAPBC 43 FASEB 43 Celladon Corporation 43 Trubion Pharma 43 Akonni 43 Immutep 43 IMCB 43 AmpliMed 43 gynecologic oncology 43 SUCCEED trial 43 Siteman 43 Wake Radiology 43 Genizon 43 FluoroPharma 43 Aestus Therapeutics 43 Principle Investigator 43 ImQuest Pharmaceuticals 43 USAMRMC 43 CDRD 43 Genomics Collaborative 43 Genomic Medicine Institute 43 MolecularMD 43 RNAi Consortium 43 INBRE 43 Celladon 43 Pharmacogenetics 43 PARTNER Trial 43 Tumor Sequencing Project 43 Trastuzumab DM1 43 ErbB2 positive 43 ActivX 43 ALS TDI 43 Paragon Bioservices 43 prostate ovarian 43 Biochemical Genetics 43 AVOREN 43 SBIR STTR 43 Tectin TM 43 ongoing Phase IIIb 43 PhytoMedical 43 Ibis Biosciences 43 Plexxikon 43 Sigma Tau Pharmaceuticals 43 afatinib 43 Gene Logic 43 LHRH receptor positive 43 Lantheus 43 number NCT# ClinicalTrials.gov 43 DermTech 43 BCAN 43 tramiprosate Alzhemed TM 43 SEER database 43 NIH institutes 43 CellSearch ™ 43 HyperAcute 43 SparVax 43 CTRI 43 Adherex Technologies 43 Adventrx 43 Neotropix 43 Structural Genomics Consortium 43 Ascenta Therapeutics 43 HGS# 43 ASHG 43 Intertech Bio 43 Kington MD Ph.D. 43 glucokinase activator 43 GELA 43 Cancer Biomarkers 43 multicenter Phase II 43 Affinitak 43 Dr. Kandzari 43 depsipeptide 43 axitinib 43 PFO migraine 43 Biomedical Computing 42 metabolomics driven 42 BCCCP 42 KLRI 42 UTHSC 42 HER2 positive metastatic breast 42 aflibercept 42 TATRC 42 AmeriPath 42 ProLindac TM 42 huN# DM1 42 Cognia 42 IMLS 42 PhG alpha 1 42 APPRAISE 42 Bert Vogelstein 42 Integral Molecular 42 ASNR 42 Helix BioPharma 42 American Cancer Society 42 Naviscan 42 molecular profiling 42 Pediatric Dengue Vaccine Initiative 42 ImmuneWorks 42 Clinical Antipsychotic Trials 42 Addrenex Pharmaceuticals 42 Entelos 42 OHRP 42 QUASAR validation study 42 Celliance 42 YONDELIS 42 Phase III psoriasis 42 GlobalNet Services 42 ONCONASE R 42 IMC A# 42 Intervention Effectiveness 42 CAMPATH 42 Craniofacial Research 42 UM Comprehensive Cancer 42 NHPCO 42 Protexia R 42 DAPT Study 42 Biodesix 42 Li Fraumeni 42 ARIAD Pharmaceuticals 42 Ocimum Biosolutions 42 deCODE ProstateCancer TM 42 Kyto 42 Dr. Ruoslahti 42 BioSphere 42 Tarvacin Anti Viral 42 NEUVENGE 42 Corgenix 42 Physician Scientist 42 NeoGenomics 42 CrystalGenomics 42 Sidney Kimmel Comprehensive Cancer 42 GVK BIO 42 CHDI 42 Autoimmune Disease 42 NIBR 42 Expression Pathology 42 VaxInnate 42 ESMO 42 RPGEH 42 Psynova 42 ImmuneRegen BioSciences 42 VentiRx 42 PROLARIS 42 Pharmacogenetics Research 42 IIa clinical 42 Proteros 42 Consortium ICGC 42 Renal Cell Carcinoma RCC 42 Chemokine 42 PLCO trial 42 GenTel 42 Veridex LLC 42 ACS 42 TSRI 42 Howard Federoff 42 MDS 42 Cogenics 42 Clovis Oncology 42 Perlegen Sciences 42 therapeutic monoclonal antibody 42 Neovastat 42 CHORI 42 VASTox 42 RE LY 42 ToGA 42 Quanterix 42 Adenosine Therapeutics 42 GeneDx 42 Kineta 42 Dana-Farber/Children s Hospital 42 MDS Pharma Services 42 INBT 42 Diatos 42 Cylex 42 Clarient 42 UTSW 42 Dana Farber 42 Translational Science Awards 42 Symphony Dynamo 42 HaptoGuard 42 Medidata Designer 42 forodesine 42 van Nagell 42 GeneMax 42 Medifacts 42 murine monoclonal antibody 42 NFCR 42 Integromics 42 Prima BioMed 42 Prostate AdenoCarcinoma Treatment 42 Ixempra 42 Indivumed 42 http:/www.cancer.gov 42 Amplimmune 42 EpiTherapeutics 42 Chemoprevention 42 Enzastaurin 42 Tumor Microenvironment 42 faulty BRCA genes 42 Epitome Biosystems 42 confirmatory clinical 42 immunotherapeutic vaccine 42 John E. Niederhuber 42 MDRF 42 Molecular Genetic 42 Kathleen Merikangas 42 evaluating Actimmune 42 CombiMatrix Molecular Diagnostics 42 ARUP Laboratories 42 ACORN CRO 42 PharmaPros 42 NIHR 42 LIPID MAPS 42 NCI Clinical Trials 42 Integrium 42 cathepsin K inhibitor 42 Curaxin CBLC# 42 eTag assays 42 UVIDEM 42 CuraGen 42 OncoTherapy Science 42 ASONEP 42 Wellstat 42 Kitware 42 diaDexus 42 Caprion 42 GVK Biosciences 42 Therapy Evaluation 42 HealthCore 42 Fuchs MD MPH 42 International HapMap Consortium 42 Neuradiab TM 42 Dr. Ronald Herberman 42 Syndax 42 Correlogic Systems Inc. 42 genomic profiling 42 Cancer Epidemiol Biomarkers Prev 42 Women Ischemia Syndrome 42 IMMCO 42 Monoclonal antibody 42 oncologists 42 DiagnoCure Oncology Laboratories 42 Coronado Biosciences 42 TransMolecular 42 LabCorp 42 VITAL Trial 42 Virulizin ® 42 Urigen 42 Zolinza 42 Micromet 42 NWBO 42 biomarker validation 42 Metastatix 42 Celldex 42 radioimmunotherapy RIT 42 GRNVAC1 42 Spirogen 42 Velcura 42 Fabry Disease 42 KRAS gene mutations 42 Kenneth Kinzler 42 Alfacell 42 Accium 42 ChromoCure 42 PKCi 42 RedPath Integrated Pathology 42 CUBRC 42 Individualized Therapy 42 Daxor 42 Locus Pharmaceuticals 42 Oncoscience 42 Aegera 42 ASRC Management 42 Ceregene 42 Response Genetics 42 sipuleucel T Provenge 42 KGK Synergize Inc. 42 TargeGen 42 Dr. Vitetta 42 Inherited Disease Research 42 Translational Breast Cancer 42 IR BioSciences Holdings 42 Bradmer 42 UAB Comprehensive Cancer 42 ASBMR 42 EVGN 42 Tufts CSDD 42 Integrated Genomics 42 BCRI 42 lorvotuzumab mertansine 42 Emanuel Petricoin 42 Morphotek 42 advanced metastatic prostate 42 TCGA Pilot Project 42 Development OOPD 42 HPV genotyping 42 Chemokine Therapeutics 42 Novelos 42 deforolimus 42 EVMS 42 prospective observational cohort 42 Oncomine 42 Abiraterone Acetate 42 Genome BC 42 please visit www.metabolon.com 42 AviaraDx 42 proteomics 42 Cellzome 42 AntiCancer 42 goBalto 42 PM DCATS 42 SCIREX 42 Outcome Sciences 42 evaluating tivozanib 42 DATATRAK 42 Ingenuity Systems 42 Dr. Henschke 42 Medical Countermeasures 42 YM BioSciences 42 Fondazione IRCCS Istituto Nazionale 42 pancreatic adenocarcinoma 42 Survivorship Program 42 Bafetinib 42 biomarker assays 42 EndoBiologics 42 Dana Farber Cancer 42 BRCA deficient 42 Clinipace 42 Onconome 42 Chemical Biology Consortium 42 Cellerant 42 Celera Genomics 42 TIMI Study Group 42 Proacta 42 LEAD Therapeutics 42 IRSF 42 Nanobac 42 NBACC 42 SeraCare 42 Innovent Oncology 42 SurroMed 42 Welichem 42 Wactawski Wende 42 Timothy Rebbeck 42 VIAP 42 Arthritis Musculoskeletal 42 UPMC Cancer 42 AASLD 42 HeFT 42 Hakon Hakonarson MD Ph.D. 42 ridaforolimus 42 ACLARA 42 ThermoDox R 42 Cytochroma 42 ASRC MS 42 Agencourt 42 HSARPA 42 Neurobiological Technologies 42 InHealth 42 NIST 42 NEJM 42 Biorepository 42 Amphora Discovery 42 Variation Biotechnologies 42 Molecular Carcinogenesis 42 Cloretazine 42 Questar Assessment 42 Evaluation WISE 42 Siteman Cancer Center 42 Odyssey Thera 41 Kidney Disease Education 41 Pacific Biometrics 41 ADMETRx 41 Dementias 41 ALTTO 41 molecular imaging 41 viral kinetic 41 CA# [006] 41 Azedra 41 caBIG ® 41 ICON7 41 Cytopia 41 PRECISE trial 41 ASPRS Foundation 41 AdMeTech Foundation 41 Phenomix 41 Medical Institute HHMI 41 REGiMMUNE 41 AnGes MG Inc. 41 RheoGene 41 UPLYSO 41 Oligonucleotide 41 Nventa 41 Caris MPI 41 HER2 amplified 41 Empire Genomics 41 Aeras 41 Arimidex anastrozole 41 Infectious Diseases NIAID 41 commercialize deforolimus 41 ONTARGET 41 TASQ 41 papillary renal cell carcinoma 41 Charlotte Kimelman 41 Juvaris 41 Allovectin 7 ® 41 Kevetrin ™ 41 Pharmatech Oncology 41 Common Terminology Criteria 41 IsoRay Medical 41 Exiqon 41 Sanger Institute 41 Gentronix 41 NO# [002] 41 EnVivo Pharmaceuticals 41 Applied Genomics 41 Phase III metastatic melanoma 41 TEIS 41 Max Neeman International 41 Clinilabs 41 Meso Foundation 41 Anaphore 41 MAGE A3 ASCI 41 Metabolon 41 Ziopharm 41 TRIST study 41 Villejuif France 41 Phase IIb clinical trials 41 Oxford Immunotec 41 drug GAP #B# 41 Gastrointestinal Oncology 41 Albain 41 PA Ioannidis 41 Experimental Therapeutics Program 41 LDRD 41 ABPP 41 Clinical Trials Agreement 41 Medicsight PLC 41 biospecimen 41 Dr. Pingpank 41 SciDAC 41 Velculescu 41 NexCura 41 PEARL SC 41 WWSS 41 Gastrotech 41 Hybridon 41 Ardais 41 Multicenter AIDS 41 BRAF mutated 41 Trophos 41 Cempra Pharmaceuticals 41 SJTRI 41 Seattle Genetics 41 Vitalea Science 41 Icoria